Skip to main content

Advertisement

SpringerLink
Log in

MicroRNA-802 promotes the progression of osteosarcoma through targeting p27 and activating PI3K/AKT pathway

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Purpose

Increasing evidences suggest dysfunctions of microRNAs (miRNAs) are playing important part in tumors. Therefore, the role of miR-802 in osteosarcoma (OS) was exploited. The object was to evaluate the effect of miR-802 and verify its influence on p27 Kip1 (p27) in OS.

Methods

RT-qPCR experiment was used to detect miR-802 and p27 expression in OS tissues and cells. We explored the function of miR-802 through Transwell assays. The phosphoinositide 3-kinase (PI3K)/AKT serine/threonine kinase pathway and epithelial–mesenchymal transition (EMT) was detected by Western blot assays. Luciferase assay was used to testify the target of miR-802.

Results

MiR-802 expression was elevated in OS, which was related to poor clinical outcome in OS patients. MiR-802 overexpression promoted OS migration, invasion and EMT. Further, p27 is a direct target of miR-802. P27 elevation counteracted the promotion effect of OS on EMT, migration and invasion induced by miR-802. In addition, miR-802 overexpression inactivated PI3K/AKT pathway via targeting p27 in OS.

Conclusion

MiR-802 promoted the progress of EMT, migration and invasion in OS via targeting p27. This newly identified miR-802/p27/PI3K/AKT axis may represent potential targets for OS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Li J, Yang Z, Li Y, et al. Cell apoptosis, autophagy and necroptosis in osteosarcoma treatment. Oncotarget. 2016;7(28):44763–78.

    Article  Google Scholar 

  2. Bhattasali O, Vo AT, Roth M, et al. Variability in the reported management of pulmonary metastases in osteosarcoma. Cancer Med. 2015;4(4):523–31.

    Article  Google Scholar 

  3. Vos HI, Coenen MJ, Guchelaar HJ, Te Loo DM. The role of pharmacogenetics in the treatment of osteosarcoma. Drug Discov Today. 2016;21(11):1775–86.

    Article  CAS  Google Scholar 

  4. Amankwah EK, Conley AP, Reed DR. Epidemiology and therapies for metastatic sarcoma. Clin Epidemiol. 2013;5:147–62.

    PubMed  PubMed Central  Google Scholar 

  5. Bishop MW, Janeway KA, Gorlick R. Future directions in the treatment of osteosarcoma. Curr Opin Pediatr. 2016;28(1):26–33.

    Article  CAS  Google Scholar 

  6. Isakoff MS, Bielack SS, Meltzer P, Gorlick R. Osteosarcoma: current treatment and a collaborative pathway to success. J Clin Oncol. 2015;33(27):3029–35.

    Article  CAS  Google Scholar 

  7. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009;10(10):704–14.

    Article  CAS  Google Scholar 

  8. Squadrito ML, Etzrodt M, De Palma M, Pittet MJ. MicroRNA-mediated control of macrophages and its implications for cancer. Trends Immunol. 2013;34(7):350–9.

    Article  CAS  Google Scholar 

  9. Zavala-Yoe R, Ramirez-Mendoza RA, Cordero LM. Entropy measures to study and model long term simultaneous evolution of children in Doose and Lennox-Gastaut syndromes. J Integr Neurosci. 2016;15(2):205–21.

    Article  Google Scholar 

  10. Liu W, Zhou Z, Zhang Q, et al. Overexpression of miR-1258 inhibits cell proliferation by targeting AKT3 in osteosarcoma. Biochem Biophys Res Commun. 2019;510(3):479–86.

    Article  CAS  Google Scholar 

  11. Ren J, Yang M, Xu F, Chen J. microRNA-758 inhibits the malignant phenotype of osteosarcoma cells by directly targeting HMGA1 and deactivating the Wnt/beta-catenin pathway. Am J Cancer Res. 2019;9(1):36–52.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Hu XH, Zhao ZX, Dai J, et al. MicroRNA-221 regulates osteosarcoma cell proliferation, apoptosis, migration, and invasion by targeting CDKN1B/p27. J Cell Biochem. 2019;120(3):4665–74.

    Article  CAS  Google Scholar 

  13. Hnit SS, Xie C, Yao M, et al. p27(Kip1) signaling: transcriptional and post-translational regulation. Int J Biochem Cell Biol. 2015;68:9–14.

    Article  CAS  Google Scholar 

  14. Kim TH, Lee HH, Chung SH, et al. Expression of p27 and Jun activation domain-binding protein 1 in endometriosis. Arch Gynecol Obstet. 2015;292(2):377–81.

    Article  CAS  Google Scholar 

  15. Shao J, Li S, Palmqvist L, et al. p27(KIP1) and PTEN cooperate in myeloproliferative neoplasm tumor suppression in mice. Exp Hematol Oncol. 2015;5:17.

    Article  Google Scholar 

  16. Montanaro L, Trere D, Derenzini M. Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential. Biochem Biophys Acta. 2012;1825(1):101–10.

    CAS  PubMed  Google Scholar 

  17. Wang Y, Zeng J, Pan J, et al. MicroRNA-200c is involved in proliferation of gastric cancer by directly repressing p27(Kip1). Biochem Biophys Rep. 2016;8:227–33.

    PubMed  PubMed Central  Google Scholar 

  18. Thomas DM, Johnson SA, Sims NA, et al. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma. J Cell Biol. 2004;167(5):925–34.

    Article  CAS  Google Scholar 

  19. Gianferante DM, Mirabello L, Savage SA. Germline and somatic genetics of osteosarcoma—connecting aetiology, biology and therapy. Nat Rev Endocrinol. 2017;13(8):480–91.

    Article  CAS  Google Scholar 

  20. Lindsey BA, Markel JE, Kleinerman ES. Osteosarcoma overview. Rheumatol Ther. 2017;4(1):25–43.

    Article  Google Scholar 

  21. Zhuang M, Qiu X, Cheng D, et al. MicroRNA-524 promotes cell proliferation by down-regulating PTEN expression in osteosarcoma. Cancer Cell Int. 2018;18:114.

    Article  Google Scholar 

  22. Gao G, Tian Z, Zhu HY, Ouyang XY. miRNA-133b targets FGFR1 and presents multiple tumor suppressor activities in osteosarcoma. Cancer Cell Int. 2018;18:210.

    Article  CAS  Google Scholar 

  23. Jiang C, Liu X, Wang M, et al. High blood miR-802 is associated with poor prognosis in HCC patients by regulating DNA damage response 1 (REDD1)-mediated function of T cells. Oncol Res. 2019;27(9):1025–34.

    Article  Google Scholar 

  24. Zhang Q, Lv R, Guo W, Li X. microRNA-802 inhibits cell proliferation and induces apoptosis in human cervical cancer by targeting serine/arginine-rich splicing factor 9. J Cell Biochem. 2019;120(6):10370–9.

    Article  CAS  Google Scholar 

  25. Zhang XY, Mu JH, Liu LY, Zhang HZ. Upregulation of miR-802 suppresses gastric cancer oncogenicity via targeting RAB23 expression. Eur Rev Med Pharmacol Sci. 2017;21(18):4071–8.

    PubMed  Google Scholar 

  26. Cao ZQ, Shen Z, Huang WY. MicroRNA-802 promotes osteosarcoma cell proliferation by targeting p27. APJCP. 2013;14(12):7081–4.

    PubMed  Google Scholar 

  27. Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol. 2014;9:287–314.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Laboratory, Weifang Weiyi Tumor Hospital, Affiliated Hospital of Weifang Medical University, Weifang, 261061, China

    L. F. Gao

  2. No.1 Department of Orthopedics, Traditional Chinese Medical Hospital of Huangdao District, Qingdao, 266500, China

    S. Jia

  3. Emergency Ward, Qingdao Hospital of Traditional Chinese Medicine, Qingdao Hiser Medical Group, Qingdao, 266033, China

    Q. M. Zhang

  4. Department of Imaging, Zhangqiu District People’s Hospital, Jinan, 250200, China

    Y. F. Xia &  C. J. Li

  5. Department of Spine Surgery, Qingdao Hospital of Traditional Chinese Medicine, Qingdao Hiser Medical Group, 4 Renmin Road, Shibei District, Qingdao, 266033, China

    Y. H. Li

Authors
  1. L. F. Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Q. M. Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y. F. Xia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. J. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Y. H. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

LG conceived and designed the study and drafted the manuscript. SJ and QZ collected, analyzed and interpreted the experimental data. YX, CL and YL revised the manuscript for important intellectual content. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Y. H. Li.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The study was approved by Ethical Committee of Weifang Weiyi Tumor Hospital and conducted in accordance with the ethical standards. Approval No. 2012-11.

Research involving human participants and/or animals

All procedures carried out in studies involbing human participants are consistent with the ethical standards of institutions and/or national research councils, as well as with the 1964 Helsinki Declaration and its subsequent amendments or similar ethical standards.

Informed consent

Subjects signed the informed consent.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, .F., Jia, S., Zhang, .M. et al. MicroRNA-802 promotes the progression of osteosarcoma through targeting p27 and activating PI3K/AKT pathway. Clin Transl Oncol 24, 266–275 (2022). https://doi.org/10.1007/s12094-021-02683-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-021-02683-w

Keywords

Search

Navigation